View contact record, Full name: Rossella Di Stasi
CNR Ibb | back to homepage
CNR Ibb | back to homepage
▲NavBar
Advanced search Ricerca avanzata▼
Query Ricerca:      Extended Estesa  
    
Photo Foto
Name NomeRossella Di Stasi
AreaResearch&Development Ricerca e Sviluppo
Position QualificaResearcher Ricercatore
Work site SedeNaples-Mezzocannone Napoli-Mezzocannone
Address IndirizzoVia Mezzocannone 16, 80134 Naples - Italy Napoli - Italia
E-mailrossella.distasicnr.it
Office phone Telefono ufficio+390812534508
Mobile phone Cellulare+393397571791
Skype IDRossella7717
▼    Cancer Diseases Malattie Neoplastiche
▼    Gadd45 beta and its implication in chronic inflammation
▼    Structural characterization of proteins and enzymes isolated from organisms living under unusual conditions
▼    Caratterizzazione della famiglia proteica delle KCTD: fattori chiave in diversi processi biologici Characterization of the KCTD protein family: key factors in several biological processes
▼    Characterization of neurotoxic and neuroprotective factors by using computational methodologies
▼    Monoclonal Antibodies for therapeutic and diagnostic applications
▼    Targeted Drug Delivery by integrin avb3 antagonist
▼    Sintesi chimica e modificazione di proteine per applicazioni in campo biomedico Chemical protein synthesis and modification for biomedical applications
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    Imaging Tumor Acidosis
▼    Bioactive peptide-membrane assemblies
No results. Nessun risultato.
▼    Carbonic Anhydrase IX as target for the development of new anti-tumour drugs L’Anidrasi Carbonica IX come target per lo sviluppo di nuovi farmaci antitumorali
▼    Carbonic Anhydrase family as target for rational drug design
▼    Clinical Oncology
▼    Translational Molecular Imaging in Cancer
▼    Molecular imaging for personalized therapy in oncology
▼    Modeling radiation induced normal tissue effects
▼    Evaluation of new molecular probes by preclinical imaging Test e validazione di nuove sonde molecolari mediante imaging preclinico
▼    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Spectroscopic and computational investigation on the potential of natural product in biomedicine. Nucleic acid and protein binding studies Sintesi di small molecules, peptidi modificati e peptidi decorati con nucleobasi. Valutazione spettroscopica e computazionale del potenziale di prodotti naturali in biomedicina. Studi di interazione molecolare con acidi nucleici e proteine
▼    Brain segmentation for radiation oncology application Segmentazione cerebrale per applicazioni in radiologia oncologica
▼    Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools Modifiche chimiche eseguite su molecole naturali, quali peptide e polisaccaridi, e loro impiego come agenti terapeutici e sonde diagnostiche
▼    Drug discovery by mirror-image phage display Drug discovery attraverso l’impiego della tecnologia del mirror-image phage display
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Other Diseases Altre Malattie
▼    Structural characterization of proteins and enzymes isolated from organisms living under unusual conditions
▼    Characterization of neurotoxic and neuroprotective factors by using computational methodologies
▼    Bioactive peptide-membrane assemblies
No results. Nessun risultato.
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    Sintesi chimica e modificazione di proteine per applicazioni in campo biomedico Chemical protein synthesis and modification for biomedical applications
▼    Comparison of noninvasive cardiac imaging modalities in patients with myocardial infarction
▼    Structural and functional studies of virulence factors in Mycobacterium tuberculosis infection
▼    Assessment of the cardiac risk and its temporal variation
▼    Carbonic Anhydrase family as target for rational drug design
▼    Evaluation of new molecular probes by preclinical imaging Test e validazione di nuove sonde molecolari mediante imaging preclinico
▼    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Spectroscopic and computational investigation on the potential of natural product in biomedicine. Nucleic acid and protein binding studies Sintesi di small molecules, peptidi modificati e peptidi decorati con nucleobasi. Valutazione spettroscopica e computazionale del potenziale di prodotti naturali in biomedicina. Studi di interazione molecolare con acidi nucleici e proteine
▼    Phenotyping of murine models by preclinical imaging Fenotipizzazione di modelli murini mediante imaging preclinico
▼    Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools Modifiche chimiche eseguite su molecole naturali, quali peptide e polisaccaridi, e loro impiego come agenti terapeutici e sonde diagnostiche
▼    Drug discovery by mirror-image phage display Drug discovery attraverso l’impiego della tecnologia del mirror-image phage display
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Macromolecules for biomedical and biotechnological applications Macromolecole per applicazioni biomediche e biotecnologiche
▼    Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives Relazione tra malattia e alterate interazioni proteina-proteina: patogenicità e prospettive terapeutiche
▼    A multi-targeting approach to fight COVID-19 Un approccio multi-targeting per combattere COVID-19
▼    Galectins: Structure, function and therapeutic potential inhibitors Galectine: struttura, funzione e potenziali inibitori terapeutici
▼    Caratterizzazione della famiglia proteica delle KCTD: fattori chiave in diversi processi biologici Characterization of the KCTD protein family: key factors in several biological processes
▼    Sintesi chimica e modificazione di proteine per applicazioni in campo biomedico Chemical protein synthesis and modification for biomedical applications
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    Biomolecular NMR: structural studies of proteins and peptides and drug discovery applications Risonanza magnetica nucleare biomolecolare: studi strutturali di proteine e peptidi e applicazioni per il “drug discovery”
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Generation of innovative scaffolds by manipulating hyperstable proteins Design di scaffold innovativi mediante l’ingegnerizzazione di proteine termostabili
▼    The fine structure of proteins as a new tool for protein structure validation, quality assessment, and prediction La strutture fine delle proteine: un nuovo strumento per la validazione e la predizione della loro struttura tridimensionale
▼    Carbonic Anhydrase IX as target for the development of new anti-tumour drugs L’Anidrasi Carbonica IX come target per lo sviluppo di nuovi farmaci antitumorali
▼    Biochemical and functional characterization of intrinsically disordered proteins (IDPs) in human diseases Caratterizzazione biochimica e funzionale di proteine intrinsecamente disordinate e loro ruolo nelle malattie umane
▼    Biochemical and functional characterization of Protein-Protein and DNA-protein Interaction networks in physio/pathological events Caratterizzazione biochimica e funzionale di interazioni proteina-proteina e DNA-proteina in eventi fisio/patologici
▼    Biochemical and structural insights on Chromatin Assembly Factor 1 in physio/pathological events Studi biochimici e molecolari sul Fattore di Assemblaggio della Cromatina 1 coinvolta in eventi fisiopatologici
▼    Plant polypeptides as natural enhancers of biostimulation Polipeptidi vegetali come potenziatori naturali della biostimolazione
▼    Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools Modifiche chimiche eseguite su molecole naturali, quali peptide e polisaccaridi, e loro impiego come agenti terapeutici e sonde diagnostiche
▼    Protein-based biotherapeutics Bioterapeutici a base di proteine
▼    Understanding SARS-CoV-2 interaction with its host of for therapeutic applications Studi di interazioni patogeno-ospite in SARS-CoV-2
▼    Structure and function of proteins involved in physio-pathologic processes Struttura e funzione di proteine coinvolte in processi fisiopatologici
▼    Carbonic Anhydrase IX as target for the development of new anti-tumour drugs L’Anidrasi Carbonica IX come target per lo sviluppo di nuovi farmaci antitumorali
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    A multi-targeting approach to fight COVID-19 Un approccio multi-targeting per combattere COVID-19
▼    Galectins: Structure, function and therapeutic potential inhibitors Galectine: struttura, funzione e potenziali inibitori terapeutici
▼    Caratterizzazione della famiglia proteica delle KCTD: fattori chiave in diversi processi biologici Characterization of the KCTD protein family: key factors in several biological processes
▼    Sintesi chimica e modificazione di proteine per applicazioni in campo biomedico Chemical protein synthesis and modification for biomedical applications
▼    Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives Relazione tra malattia e alterate interazioni proteina-proteina: patogenicità e prospettive terapeutiche
▼    Biomolecular NMR: structural studies of proteins and peptides and drug discovery applications Risonanza magnetica nucleare biomolecolare: studi strutturali di proteine e peptidi e applicazioni per il “drug discovery”
▼    Structural characterization of the porphyrins/proteasome interaction Caratterizzazione strutturale dell’interazione porfirine/proteosoma
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Drug discovery by mirror-image phage display Drug discovery attraverso l’impiego della tecnologia del mirror-image phage display
▼    Analysis of Sam domain druggability through computational and experimental studies I domini Sam come bersagli farmacologici: studi computazionali e sperimentali
▼    Targeting Sam-Sam interactions mediated by EphA2 receptor: design and evaluation of peptide inhibitors Progettazione e validazione di peptidi inibitori delle interazioni Sam-Sam mediate dal recettore EphA2
▼    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Spectroscopic and computational investigation on the potential of natural product in biomedicine. Nucleic acid and protein binding studies Sintesi di small molecules, peptidi modificati e peptidi decorati con nucleobasi. Valutazione spettroscopica e computazionale del potenziale di prodotti naturali in biomedicina. Studi di interazione molecolare con acidi nucleici e proteine
▼    Biochemical and functional characterization of intrinsically disordered proteins (IDPs) in human diseases Caratterizzazione biochimica e funzionale di proteine intrinsecamente disordinate e loro ruolo nelle malattie umane
▼    Biochemical and functional characterization of Protein-Protein and DNA-protein Interaction networks in physio/pathological events Caratterizzazione biochimica e funzionale di interazioni proteina-proteina e DNA-proteina in eventi fisio/patologici
▼    Biochemical and structural insights on Chromatin Assembly Factor 1 in physio/pathological events Studi biochimici e molecolari sul Fattore di Assemblaggio della Cromatina 1 coinvolta in eventi fisiopatologici
▼    Targeting Of Protein-Protein Interactions For Therapeutic Purposes Targeting delle interazioni proteina-proteina per scopi terapeutici
▼    Small molecules and peptides/modified peptides for diagnostic, therapeutic and biotechnological applications Piccole molecole e peptidi/peptidi modificati per applicazioni diagnostiche, terapeutiche e biotecnologiche
▼    Biomolecole in grado di modulare l’angiogenesi VEGF-dipendente Biomolecules able to modulate the VEGF-dependent angiogenesis
▼    New peptide–based molecules as NGF mimetics in the therapy of neurological dysfunctions Nuove molecole di natura peptidica che mimano l’NGF per la terapia di malattie neurologiche
▼    Peptide-based molecules for αvβ3 integrin modulation in Th17 cells-dependent demyelinating diseases Molecole di natura peptidica per modulare l’attività dell’integrina αvβ3 nelle malattie demielinizzanti Th17 dipendenti
▼    Development of integrin subtypes selective ligands: from a first rationally designed peptide to a wide range of molecules Sviluppo di ligandi selettivi per i sottotipi di integrine: dal primo peptide progettato su base razionale verso un ampio spettro di molecole
▼    Design of New FSHR-Specific Peptides for therapeutic and diagnostic applications Progettazione di nuovi peptidi specifici per il recettore dell’FSH per applicazioni diagnostiche e terapeutiche
▼    New synthetic molecules for active targeting of multifunctional theranostic nanosystems Nuove molecole sintetiche per il trasporto attivo di nanosistemi multifunzionali teranostici
▼    Biomolecular NMR: structural studies of proteins and peptides and drug discovery applications Risonanza magnetica nucleare biomolecolare: studi strutturali di proteine e peptidi e applicazioni per il “drug discovery”
▼    Galectins: Structure, function and therapeutic potential inhibitors Galectine: struttura, funzione e potenziali inibitori terapeutici
▼    Protein-Protein-Interaction network–disease relationship, pathogenicity and therapeutic perspectives Relazione tra malattia e alterate interazioni proteina-proteina: patogenicità e prospettive terapeutiche
▼    A multi-targeting approach to fight COVID-19 Un approccio multi-targeting per combattere COVID-19
▼    Axl and Gas6 targeting for therapeutic and diagnostic applications Molecole che bersagliano Axl e Gas6 per applicazioni a scopo terapeutico e diagnostico
▼    Drug discovery by mirror-image phage display Drug discovery attraverso l’impiego della tecnologia del mirror-image phage display
▼    Peptides of therapeutic interest with antimicrobial and/ or antitumoral activity Peptidi di interesse terapeutico con attività antimicrobica e/o antitumorale
▼    Analysis of Sam domain druggability through computational and experimental studies I domini Sam come bersagli farmacologici: studi computazionali e sperimentali
▼    Targeting Sam-Sam interactions mediated by EphA2 receptor: design and evaluation of peptide inhibitors Progettazione e validazione di peptidi inibitori delle interazioni Sam-Sam mediate dal recettore EphA2
▼    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Spectroscopic and computational investigation on the potential of natural product in biomedicine. Nucleic acid and protein binding studies Sintesi di small molecules, peptidi modificati e peptidi decorati con nucleobasi. Valutazione spettroscopica e computazionale del potenziale di prodotti naturali in biomedicina. Studi di interazione molecolare con acidi nucleici e proteine
▼    Plant polypeptides as natural enhancers of biostimulation Polipeptidi vegetali come potenziatori naturali della biostimolazione
▼    Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools Modifiche chimiche eseguite su molecole naturali, quali peptide e polisaccaridi, e loro impiego come agenti terapeutici e sonde diagnostiche
▼    Design and screening of molecular repertoires as a source for new bioactive compounds Progettazione e screening di repertori molecolari come fonte di nuovi composti bioattivi
▼    Targeting Of Protein-Protein Interactions For Therapeutic Purposes Targeting delle interazioni proteina-proteina per scopi terapeutici
Empty curriculum Curriculum vuoto
Advanced search Ricerca avanzata▼
Content Contiene: [X]      Extended Estesa     Authors Autori: [X]  Paper type Tipo di lavoro: [X]   Start date Data iniziale: End date Data finale: [X]      Site Sede: IBB affiliation Affiliazione IBB     
    
[Clear form Pulisci modulo]
End of page Vai a fine pagina   Copy&Paste Friendly Versione per copia e incolla facile   Export all to Esporta tutto in BibTeX   Export all to Esporta tutto in EndNote

Publications Pubblicazioni
Sort by Ordina per:   date a ▼▲   title titolo ▲ ▼   journal rivista ▲ ▼   authors autori ▲ ▼   impact factor ▲ ▼
* Biochemical and Conformational Characterization of Recombinant VEGFR2 Domain "7" (172 views visite)
Di Stasi R, Diana D, De Rosa L, Fattorusso R, D'Andrea LD
Mol Biotechnol (ISSN: 1073-6085linking, 1559-0305electronic), 2019 Nov; 61(11): 860-872.
Impact Factor: 2.275
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Labeling of VEGFR1D2 through oxime ligation (161 views visite)
De Rosa L, Di Stasi R, Longhitano L, D'Andrea LD
Bioorg Chem (ISSN: 0045-2068linking, 1090-2120electronic), 2019 Jul 29; 91: 103160-103160.
Impact Factor: 3.926
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Structural studies of the binding of an antagonistic cyclic peptide to the VEGFR1 domain "2" (188 views visite)
Wang L, Coric P, Broussy S, Di Stasi R, Zhou L, D'Andrea LD, Ji L, Vidal M, Bouaziz S, Liu WQ
Eur J Med Chem (ISSN: 0223-5234linking, 1768-3254, 1768-3254electronic), 2019 May 1; 169: 65-75.
Impact Factor: 2.882
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Human Recombinant VEGFR2D4 Biochemical Characterization to Investigate Novel Anti-VEGFR2D4 Antibodies for Allosteric Targeting of VEGFR2 (237 views visite)
Di Stasi R, De Rosa L, Diana D, Fattorusso R, D'Andrea LD
Mol Biotechnol (ISSN: 1073-6085linking, 1559-0305electronic), 2019 Apr 26; 61(7): 513-520.
Impact Factor: 2.275
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Total chemical synthesis by native chemical ligation of the all-D immunoglobulin-like domain 2 of Axl (141 views visite)
De Rosa L, Di Stasi R, D'Andrea LD
Tetrahedron, 2019; N/D: N/D-N/D.
Impact Factor: 2.377
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Pro-angiogenic peptides in biomedicine (340 views visite)
De Rosa L, Di Stasi R, D'Andrea LD
Arch Biochem Biophys (ISSN: 0003-9861), 2018; 660: 72-86.
Impact Factor: 3.118
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* VEGFR Recognition Interface of a Proangiogenic VEGF-Mimetic Peptide Determined In Vitro and in the Presence of Endothelial Cells by NMR Spectroscopy (289 views visite)
Di Stasi R, Diana D, Capasso D, Di Gaetano S, De Rosa L, Celentano V, Isernia C, Fattorusso R, D'Andrea LD
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2018; 24(44): 11461-11466.
Impact Factor: 5.16
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Unveiling a VEGF-mimetic peptide sequence in the IQGAP1 protein (293 views visite)
Capasso D, Di Gaetano S, Celentano V, Diana D, Festa L, Di Stasi R, De Rosa L, Fattorusso R, D'Andrea LD
Mol Biosyst (ISSN: 1742-206x), 2017 Jul 25; 13(8): 1619-1629.
Impact Factor: 2.759
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response (361 views visite)
De Rosa L, Finetti F, Diana D, Di Stasi R, Auriemma S, Romanelli A, Fattorusso R, Ziche M, Morbidelli L, D'Andrea LD
Sci Rep (ISSN: 2045-2322, 2045-2322electronic, 2045-2322linking), 2016 Aug 08; 6: 31295-31295.
Impact Factor: 4.259
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Peptides Interacting with Growth Factor Receptors Regulating Angiogenesis (322 views visite)
Di Stasi R, De Rosa L, Romanelli A, D'Andrea LD
Frontiers In Medicinal Chemistry, 2016; 9: 103-160.
Impact Factor: 0
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Functional Binding Surface Of A Beta-Hairpin Vegf Receptor Targeting Peptide Determined By Nmr Spectroscopy In Living Cells (396 views visite)
Diana D, Russomanno A, De Rosa L, Di Stasi R, Capasso D, Di Gaetano S, Romanelli A, Russo L, D'Andrea LD, Fattorusso R
Chemistry (ISSN: 0947-6539, 1521-3765, 1521-3765electronic), 2015 Jan 2; 21(1): 91-95.
Impact Factor: 5.771
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Structure and biological activity of a conformational constrained apolipoprotein A-I-derived helical peptide targeting the protein haptoglobin (332 views visite)
Cigliano L, De Rosa L, Diana D, Di Stasi R, Spagnuolo MS, Maresca B, Fattorusso R, D'Andrea LD
Rsc Adv (ISSN: 2046-2069), 2014; 4(93): 51353-51361.
Impact Factor: 3.84
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Analysis of the haptoglobin binding region on the apolipoprotein A-I-derived P2a peptide (312 views visite)
Spagnuolo MS, Di Stasi R, De Rosa L, Maresca B, Cigliano L, D'Andrea LD
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2013 Apr; 19(4): 220-226.
Impact Factor: 1.862
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Structural investigation of the VEGF receptor interaction with a helical antagonist peptide (328 views visite)
Diana D, Di Stasi R, De Rosa L, Isernia C, D'Andrea LD, Fattorusso R
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2013 Apr; 19(4): 214-219.
Impact Factor: 1.862
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis (463 views visite)
Finetti F, Basile A, Capasso D, Di Gaetano S, Di Stasi R, Pascale M, Turco CM, Ziche M, Morbidelli L, D'Andrea LD
Biochem Pharmacol Biochemical Pharmacology (ISSN: 0006-2952, 1873-2968), 2012 Sep 1; 84(3): 303-311.
Impact Factor: 4.576
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* C-terminal truncation of Vascular Endothelial Growth Factor mimetic helical peptide preserves structural and receptor binding properties (315 views visite)
Ziaco B, Diana D, Capasso D, Palumbo R, Celentano V, Di Stasi R, Fattorusso R, D'Andrea LD
Biochem Biophys Res Commun (ISSN: 0006-291x), 2012 Jul 27; 424(2): 290-294.
Impact Factor: 2.406
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Beta-Hairpin Peptide That Targets Vascular Endothelial Growth Factor (vegf) Receptors: Design, Nmr Characterization, And Biological Activity (509 views visite)
Diana D, Basile A, De Rosa L, Di Stasi R, Auriemma S, Arra C, Pedone C, Turco MC, Fattorusso R, D'Andrea LD
Jbc Papers (ISSN: 1083-351x, 0021-9258, 0021-9258linking), 2011 Dec 2; 286(48): 41680-41691.
Impact Factor: 4.773
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo (411 views visite)
Basile A, Del Gatto A, Diana D, Di Stasi R, Falco A, Festa M, Rosati A, Barbieri A, Franco R, Arra C, Pedone C, Fattorusso R, Turco MC, D'Andrea LD
J Med Chem (ISSN: 1520-4804, 0022-2623, 0022-2623print), 2011 Mar 10; 54(5): 1391-1400.
Impact Factor: 5.248
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Bioinorganic aspects of angiogenesis (348 views visite)
D'Andrea LD, Romanelli A, Di Stasi R, Pedone C
Dalton T (ISSN: 1477-9234, 1477-9226, 1477-9234electronic), 2010 Sep 7; 39(33): 7625-7636.
Impact Factor: 3.647
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Biochemical and Structural Analysis of the Binding Determinants of a Vascular Endothelial Growth Factor Receptor Peptidic Antagonist (386 views visite)
Gautier B, Goncalves V, Diana D, Di Stasi R, Teillet F, Lenoir C, Huguenot F, Garbay C, Fattorusso R, D'Andrea LD, Vidal M, Inguimbert N
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2010 Jun 10; 53(11): 4428-4440.
Impact Factor: 5.207
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* VEGFR1(D2) in drug discovery: Expression and molecular characterization (295 views visite)
Di Stasi R, Diana D, Capasso D, Palumbo R, Romanelli A, Pedone C, Fattorusso R, D'Andrea LD
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2010; 94(6): 800-809.
Impact Factor: 2.572
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner (621 views visite)
Dudar GK, D'Andrea LD, Di Stasi R, Pedone C, Wallace JL
Am J Physiol Gastrointest Liver Physiol American Journal Of Physiology Gastrointestinal And Liver Physiology (ISSN: 0193-1857), 2008 Sep; 295(2): G374-G381.
Impact Factor: 3.587
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* Vascular Endothelial Growth Factor (VEGF) and its receptors: key regulators of angiogenesis (238 views visite)
Di Stasi R, Capasso D, Diana D, Fattorusso R, Pedone C, D'Andrea LD
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2008 Sep; 14(8): N/D-N/D.
Impact Factor: 1.654
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote

* In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with Tc-99m-tricarbonyl (369 views visite)
D'Andrea LD, Testa I, Panico M, Di Stasi R, Carac C, Tarallo L, Arra C, Barbieri A, Romanelli A, Aloj L
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2008; 90(5): 707-712.
Impact Factor: 2.823
View Dettagli    Export to Esporta in BibTeX    Export to Esporta in EndNote



24 Records (23 excluding Abstracts and Conferences escludendo Abstract e Conferenze).
Total impact factor Impact factor totale: 78.859 (77.205 excluding Abstracts and Conferences escludendo Abstract e Conferenze).
Total 5 year impact factor Impact factor a 5 anni totale: 77.179 (75.397 excluding Abstracts and Conferences escludendo Abstract e Conferenze).


Last modified by Ultima modifica di Gennaro Angrisano on in data Wednesday 22 July 2020, 10:38:48
2553 views visite. Last view on Ultima visita in data Friday 23 April 2021, 15:17:38